Eric S Jacobsen

Eric S Jacobsen (President, Upstream) sold 25,000 shares of BKV at $26.89 on 2026-06-01 via pre-arranged 10b5-1 plan; stock down -15.1% in 30 days.

Eric S Jacobsen sold 25,000 shares worth $672,145.00 on 2026-06-01 under a pre-arranged 10b5-1 trading plan adopted on 2025-11-11, reducing his holdings from 252,843 shares to 227,843 shares. The sale is scheduled and not discretionary. At his prior sale on 2026-05-01, the 30-day return was -14.3%, and this current period shows a 30-day change of -15.1%, consistent with a softer short-term environment for the stock. The company's fundamentals remain solid with annual revenue growth of +47.8%, net income of $44,075,000.00, and a P/E of 9.84, though the stock trades -19.0% from its 52-week high of $32.81 and down -15.2% over 90 days.

BKV upstream president Eric Jacobsen sells ~$774K in shares near 52-week highs amid strong revenue growth.

Eric Jacobsen, BKV's President of Upstream operations, sold a material block of shares worth approximately three-quarters of a million dollars at prices hovering near the company's recent highs, disposing of about 9% of his holdings. The company itself remains financially healthy—profitable with strong recent revenue growth and a reasonable valuation multiple—suggesting this sale is not a distress signal about underlying business fundamentals. However, the timing is noteworthy: the sale occurred when the stock was trading within a fraction of its 52-week peak, which is atypical for insider purchases but common for executives rebalancing portfolios or taking profits after a period of gains. Without additional context on vesting schedules, compensation planning, or concurrent insider activity, this appears to be a routine portfolio adjustment by an operational executive rather than a loss-of-confidence signal.

BKV President Jacobsen sells 31,350 shares at $22.02 amid -18.2% revenue decline, unprofitable FY

Jacobsen Eric S, President of Upstream at BKV, sold 31,350 shares at $22.02 on 2025-05-19, reducing holdings by 10.8% to 257,903 shares. The sale occurs in a challenging fundamental environment: the company reported -18.2% annual revenue growth and posted a full-year net loss of $-78,666,000. At current price of $21.93, the stock trades 17.2% below its 52-week high, though it has risen 25.2% over the past 30 days. Jacobsen's prior open-market sell activity shows an average 30-day return of -7.3%, and his two prior BKV sales (most recent on 2025-05-09) do not yet show measurable 90-day outcomes. The sale represents a discrete reduction of insider stake during a period of operational headwinds and negative profitability.

BKV President Eric Jacobsen sold 31,350 shares at $20.01; stock now at $21.78 amid -18.2% annual revenue decline, $-78.7M net loss.

Jacobsen sold 31,350 shares (9.8% of his pre-transaction holdings of 320,603 shares) on 2025-05-09 at $20.01, with BKV trading at $21.78 today. The transaction is material in absolute size ($627,319.77) and timing context: the stock has risen 31.7% in the 30-day window since the sale, and Jacobsen's same-ticker prior sale on 2025-04-03 showed a 30-day return of -7.3%. More significantly, BKV fundamentals show acute stress—annual revenue declined 18.2% year-over-year to $231,011,000.00 in the latest quarter, while the company posted a net loss of $-78,666,000.00 and remains unprofitable on a full-year basis. His cross-ticker sell track record averaged -7.3% returns over 30 days, a modest negative signal, though his timing pattern across all trades (0 of 0 prior sells well-timed at 90-day mark) provides limited statistical precedent. The sale during a period of deteriorating profitability and revenue contraction, coupled with the stock's subsequent outperformance relative to his sale price, warrants investor scrutiny of BKV's operational trajectory.

BKV President Jacobsen sells 31,350 shares at $20.06; stock down 35.4% from 52-week high despite recent profitability.

Jacobsen Eric S, President of Upstream, sold 31,350 shares at $20.06 on 2025-04-03, reducing his holdings by 31,350 shares from 351,953 to 320,603 shares. The transaction occurred while the stock trades at $17.11, down 35.4% from its 52-week high of $26.49, a significant deterioration in valuation since his sale date. The company's fundamentals are mixed: while it posted net income of $12,869,000 in the latest quarter, its full-year net income was negative, and annual revenue contracted 18.2% year-over-year, suggesting operational headwinds. The sale price of $20.06 was above current market levels, meaning Jacobsen exited at a premium to today's price, and his remaining 320,603 share position still represents substantial equity exposure to a company facing revenue declines and full-year losses.